global-solid-tumor-therapeutics-market Global Solid Tumor Therapeutics Market

customer service software

Global Solid Tumor Therapeutics Market

  • Published Date: 11 Nov 2018
  • Number of Pages: 174
  • Category: Healthcare and Medical
  • Country: Global
Solid tumor therapeutics are those pharmaceuticals which specifically treat various types of cancers such as breast cancer, lung cancer, prostate cancer, colorectal cancer, cervical cancer and others. Solid tumors are an abnormal mass of tissue that usually does not contain cysts or liquid areas. They are of two types, namely benign and malignant. The treatment of solid tumors requires synchronized actions of many healthcare professionals, such as surgeons, radiation specialists, oncologists, radiologists and other professionals. Hence, most of the solid tumors are treated with chemotherapy, radiotherapy, and/or surgery. At present, surgery is the most appropriate treatment option for cancer solid tumors.

Market Dynamics

According to WHO, around 8 million people died with various forms of cancer around the world in 2012, the number of new cases is expected to rise by about 70% over the next 2 decades. Thus, increasing incidences of solid tumor among cancer patients and growing prevalence of various types of metastatic cancers are the fundamental factors that are expected to drive the growth of the global solid tumor therapeutics market. Other key factors that will propel the growth of the market are as follows- increasing investment in R&D of therapeutics, increasing expenditure in healthcare, unmet need for efficacious drug and growing competition for new drugs. However, the increasing cost of R&D, high cost of therapy, drugs going off patent and increasing generic products are restricting the growth of the market.

Market Segmentation

The solid tumor therapeutics market has been segmented based on the type of cancer, type of therapy and geography. On the basis of type of cancer, the market is classified as breast cancer, lung cancer, colorectal cancer, prostate cancer, cervical cancer and others. The segmentation on types of therapy includes the following: Chemotherapy, Hormone therapy, Immunotherapy and Targeted therapy.

Regional/Geographic Analysis

The market can be segmented on the basis of geography into North America, Europe, Asia-Pacific, Middle East & Africa and South America. The North American region has been further subdivided into USA, Mexico, and Canada. The Europe region has been segmented into Germany, France, Italy UK, Spain, and Rest of Europe. The Asia-Pacific market is segregated into Japan, China, India, South Korea, New Zealand, Australia and Rest of Asia-Pacific. The Middle East & African market have been subdivided into GCC countries, South Africa and rest of the Middle East and Africa. The South American market has been segmented into Brazil, Argentina and rest of South America. Currently, North America accounts for the largest market share.

Key Players

Some of the major players in the market are Kyowa Hakko Kirin Co. Ltd., GlaxoSmithKline plc, Johnson & Johnson, BoehringerIngelheim GmbH, Eli Lilly and Company, AstraZeneca plc, F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, Baxter International Inc., Biogen Idec, Amgen, Inc., Abbott Laboratories, Inc., Sanofi and others.The

Report Contents:

> Market segments
> Market Drivers, Restraints and Opportunities
> Market Size & Forecast 2016 to 2022
> Supply & Demand Value Chain
> Market - Current Trends
> Competition & Major Companies
> Technology and R&D Status
> Porters Five Force Analysis
> Strategic and Critical Success Factor Analysis of Key Players

Regional Analysis:

> North America

>> US and Canada

> Latin America

>> Mexico, Brazil, Argentina and Rest of Latin America

> Western Europe

>> EU5 (Germany, France, Italy, Spain, U.K.)
>> Nordic Countries (Denmark, Finland, Norway, and Sweden)
>> Benelux (Belgium, The Netherlands, and Luxembourg)
>> Rest of Western Europe

> Eastern Europe

>> Russia
>> Poland
>> Rest of Eastern Europe

> Asia Pacific

>> China
>> India
>> Japan
>> Australia and New Zealand
>> Rest of Asia Pacific

> Middle East and Africa

>> GCC countries (Saudi Arabia, Oman, Qatar, Bahrain, UAE and Kuwait)
>> South Africa
>> North Africa
>> Rest of Middle East and Africa

This report is an elaborate aggregation of primary inputs from industry experts and participants across the supply chain. It provides details on market segmentation which is derived from several product mapping exercises, macroeconomic parameters and other qualitative and quantitative insights. The impact of all such factors is delivered across multiple market segments and geographies.

Report Highlights:

> Detailed Historical Overview (Market Origins, Product Launch Timeline, etc.)
> Consumer and Pricing Analysis
> Market dynamics of the industry
> Market Segmentation
> Estimated Market Sizing in terms of volume and value
> Recent trends in Market and impact
> Research Status and Technology Overview
> Extensive Industry Structure Coverage

Publisher Name : Market Litmus

Global sarcopenia treatment market is valued approximately USD 2208.4 billion in 2017 and is anticipated to grow with a healthy growth rate of more than 4.8% over the forecast period

View Report

The global market size of Skull Operating Rack is $XX million in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million by the

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit -

Cick Here